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faecium Population
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Abstract
Horizontal gene transfer constitutes a key driving force in bacterial evolution. 
The ability to acquire mobile genetic elements encoding antimicrobial resistance 
has contributed to the emergence of Enterococcus faecium as one of the main human 
nosocomial opportunistic pathogens. The deep analysis of the vancomycin-resistant 
E. faecium (VREfm) population’s mobilome, as the architecture and evolution of the 
core genome enables to observe VREfm plasticity and power of adaptation in ani-
mals, plants, environment and food. The persistence of VREfm is facilitated by the 
exchange of plasmids, phages and conjugative transposons that have allowed them 
to achieve a rapid adaptation to changes in environmental conditions. They can 
acquire resistance determinants from several species and transfer resistance genes 
to other potentially pathogenic bacteria such as methicillin-resistant Staphylococcus 
aureus strains.
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1. Introduction
Enterococcus faecium is a main bacterial agent of healthcare-associated infections 
in immunocompromised as well as severely ill patients, with a worldwide distribu-
tion [1, 2].
In 1988, vancomycin-resistant E. faecium (VREfm) was reported for the first 
time. Along the 1990s, a fast increase of infectious diseases due to this bacterium 
was detected in the United Kingdom hospitals, linking its emergence with the 
employment of the glycopeptide avoparcin in animal husbandry for food industry. 
In addition, at U.S hospitals it was observed the emergence of VREfm, but with not 
proved association to the use of avoparcin in animals [3–5].
The World Health Organization’s global priority pathogens list of antibiotic-
resistant bacteria has categorized VREfm as of high priority. For infectious diseases 
produced by VREfm, it has been reported that the therapeutic options are more lim-
ited, altogether with higher mortality rates and financial costs for the Health system 
when compared with vancomycin-susceptible enterococci [6, 7].
Food chain can be considered as one possible way of VREfm spread or for the 
transfer of its antimicrobial resistance genes to humans, as it has been reported for 
cattle, pork and poultry meat [5, 8].
In the European Union, despite the avoparcin ban 18 years ago, VREfm circula-
tion in the environment has continued. A likely cause of vancomycin-resistance 
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plasmid genes persistence is the co-selection of other antimicrobials used in 
animals, such as macrolides or narasin, as it has been suggested by the presence of 
ermB type transporter genes (macrolide-lincosamide-streptogramin B resistance), 
as well as ABC type transporter genes and the presence of a toxin/anti-toxin system. 
Other possibilities which can relate with VREfm spread is their persistence in food 
farms, slaughterhouses or their environments due to poor hygienic conditions or 
through avian transmission [9–11].
It is important to highlight that, enterococci, as part of human and animal 
intestinal microbiota, are able to acquire resistance genes from other commensal 
bacteria, which can be spread as well to other pathogenic bacteria [12, 13].
Evolution of E. faecium from intestinal commensal bacteria to opportunistic 
pathogen is a complex and sequential process, in which seem to have been involved 
different factors, such as resistance and virulence determinants acquisition and 
persistence. Their expression is assumed to give an adaptive advantage since these 
factors facilitate the colonization of different epithelial cells (urinary, oral or intes-
tinal), and at the same time, the bacterial adhesion to a wide variety of extracellular 
matrix proteins.
2. VREfm: natural and acquired antimicrobial resistance
E. faecium is intrinsically resistant to penicillin, ampicillin, cephalosporins and 
other β-lactams by mutations in the penicillin-binding protein PBP5 that is encoded 
by a horizontally transferred gene. Globally, enterococci are in vivo resistant to 
clindamycin (efflux pumps), trimethoprim-sulfamethoxazole (missing target) and 
the majority of aminoglycosides (enzymatic degradation). Furthermore, E. faecium 
has been acquiring resistance to quinolones, rifampicin and chloramphenicol, 
through mutations or by horizontal gene transfer [14–18].
In regard with vancomycin resistance, only the vanA and vanB genotypes are 
epidemiologically relevant in clinical isolates. In this sense, the vanA cluster is the 
most prevalent glycopeptide resistance determinant in clinical settings. Recently, 
the presence of vanB cluster has increased in Europe, while is the main vancomycin 
resistance mechanism in Australia. These genotypes are associated with mobile 
genetic elements. The vanA gene cluster is generally part of the Tn3-family trans-
poson Tn1546. Among vanB cluster, vanB2 is the most frequent subtype and consti-
tutes an integral part of the integrative conjugative element Tn1549/5382 [19–23].
2.1 The VREfm-mobilome
The mobilome is defined as all the mobile genetic elements (MGEs) able to move 
around within or between genomes. MGEs contribute to genome plasticity and 
dissemination of antimicrobial resistance and pathogenicity bacterial genes. In E. 
faecium, the acquisition of exogenous DNA is involved in the change of a commen-
sal bacterium for becoming a pathogenic strain [24].
Horizontal gene transfer (HGT) allows the exchange of genetic material 
between bacteria. The most important HGT mechanism is conjugation, where 
the type IV secretion systems create channels between bacterial cells for transfer-
ring DNA.
The others mechanisms involved in HGT are transformation, in which 
bacteria are able to internalize naked DNA located in their immediate environ-
ment, and transduction, in which DNA is trapped within bacteriophages that 
have infected a bacterial cell and, then, is released and inserted into the genome 
of a new cell after bacteriophage transmission. Other gene transfer mechanisms 
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as nanotubes, micro-vesicles and gene-transfer agents have not been described in 
enterococci yet [25, 26].
There have been described three mechanisms of attack and defense interacting 
with HGT, toxin-antitoxin (T/A) systems, restriction/modification (R/M) systems 
and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas 
enzymes.
• T/A systems are small elements conformed by a toxin gen and its related anti-
toxin. Plasmid-encoded TA elements are important for plasmid maintenance. 
There are five types of T/A systems but only type 2 is prevalent in enterococci. 
In E. faecium, type 2 T/A systems comprise Axe/Txe and omega/epsilon/
zeta. These plasmid-located T/A systems are enriched in clinical multi-drug 
resistant isolates [26–28].
• R/M systems, in which a restriction enzyme cleaves in a specific unmethyl-
ated DNA site and other enzyme links a methyl group to the same site; thus, 
DNA cleavage is blocked. This system contributes with the regulation of gene 
exchange in E. faecium [29].
• CRISPR-Cas systems constitute endogenous barriers to HGT in bacteria. A set 
of genes (cas) encoding nucleases are located near the CRISPR. Nosocomial 
clade of E. faecium is in great measure deficient of the CRISPR-Cas systems 
[30]. This fact is associated with the increased presence of MGEs. Conversely, 
commensal E. faecalis contain type II CRISPR-Cas systems, but multi-drug 
resistant (MDR) strains not carry complete CRISPR systems. Thus, MDR E. 
faecalis are prone for acquiring antibiotic resistance genes [31].
Among enterococci, different types of DNA arrangements and/or MGEs can be 
found, such as insertion sequences (IS), pathogenicity islands (PAIs), transposons 
(Tn) and plasmids.
IS are DNA segments (0.5–2 kb) able to autonomously move and to be found 
integrated in any replicon, in chromosomes as well as in plasmids. When IS appear 
in the middle of genes, they can interrupt the encoding sequence and inactivate the 
gene expression.
PAIs are fractions of a microorganism’s genomic DNA linked with encoding 
sequences for virulence traits, such as adhesins, host immune evasion factors, 
toxins, cell components lytic enzymes, among others. Usually, PAIs are included 
in plasmids and their origin is associated with horizontal transfer of genetic 
material.
Tn are genetic elements that are directly movable as DNA and can harbor adap-
tive functions such as an antimicrobial resistance mechanism.
Plasmids are small extrachromosomal DNAs that can replicate independently 
(replicons). In enterococci, these genetic elements are wide-spread. Plasmid size 
is variable and is reflected in the number of genes they contain and the range of 
encoded functions. Plasmids are able to include antimicrobial resistance genes, 
stability modules and conjugation modules. In addition, are termed conjugative 
plasmids when they encode the type IV secretion system (T4SS) and are mobiliz-
able if they contain the origin of transfer (oriT) and the relaxase protein, type IV 
coupling protein T4CP. In enterococci, plasmid replication proteins may be classi-
fied by mode of replication, sequence similarity and subdomains present within the 
translated gene. Replication proteins replicate the plasmids by unidirectional lead-
ing strand Rolling Circle Replication (RCR) and by bi-directional Theta (q) replica-
tion. RCR plasmids are frequently small, cryptic and unstable over a 10–15 kb size.
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A plasmid typing method based on the replication regions from various plasmid 
incompatibility groups was described in enterococci and other Gram-positive 
bacteria, and 19 replicon families (rep-family) and some unique replicons were 
found [32].
The q plasmids are subdivided into replicon families: Rep_3, Inc18 and RepA_N:
• Rep_3 plasmids: narrow host range of similar size to RCR plasmids and often 
cryptic.
• Inc18 plasmids: often conjugative (25–50 kb) broad host-range plasmids; most 
of them harbor resistance determinants.
• RepA_N plasmids (10–300 kb): prevalent in low G + C content Gram positive 
bacteria with a narrow host range.
This scheme can be modified by recombination, leading to mosaic structures 
[26, 33–36].
The pheromone-responsive plasmids have been described mainly in E. faecalis; 
pAD1 and pCF10 were the first described.
Different plasmid diversity between VREfm and E. faecalis strains producers of 
nosocomial infections can be observed. VREfm, mainly CC17, show many rep types 
as rep11 (pB82), rep14 (pRI1), rep18 (pEF418), repunique (pC1Z2) rep1 and rep2 (Inc18), 
rep17 (pRUM), repunique (pHTβ) were found. Vancomycin-resistant E. faecalis carry a 
lower diversity of plasmid, generally associated with rep9 type (pheromone respon-
sive pAD1), rep1 and rep2 (Inc-18 type) as well [34].
The presence of big transferable plasmids, also known as megaplasmids 
(>150 kb) is common among clinical isolates of E. faecium, and can have a role 
related with their virulence. Often, these plasmids contain genes linked with 
different carbohydrates metabolism, such as hylEfm gene. Initially, it was suggested 
that this gene encoded for a hyaluronidase. Nevertheless, more recent sequencing 
studies showed that, actually, this gene encodes for a glycosyltransferase which 
allows the utilization of complex carbohydrates. Furthermore, it has been proven 
that the transfer of these MGEs to non-carrying plasmid commensal strains of 
E. faecium, will increase their virulence and their gastrointestinal colonization 
capability [19, 33, 37].
Worldwide, most of the VREfm strains recovered in clinical settings were 
included into the clonal complex 17 (CC17). Afterwards, they were divided into 
three lineages (17, 18 and 78), using multilocus sequence typing studies (MLST). 
More recently, the Bayesian Analysis of Population Structure (BAPS), applied to 
MLST data established two nosocomial groups: 2–1 (lineage 78) and 3–3 (lineages 
17/18). All CC17 E. faecium strains contain many exogenously acquired genes such 
as IS, phages, and Tn encoding antimicrobial resistance. Furthermore, hospital-
adapted VREfm are ciprofloxacin and ampicillin-resistant, with virulence traits also 
found in theirs genomes. VREfm strains have cell surface protein genes, regulatory 
genes, putative PAIs, plasmids, IS and integrated phages, which promote their 
adaptation to the healthcare-associated environment. The IS16 and the esp gene are 
carried by an integrative conjugative element (ICEEfm1) with the intA integrase 
gene, and are considered as markers of nosocomial E. faecium strains [5, 17, 29].
In E. faecium CC17, the location of hylEfm gene was described in a large conjuga-
tive plasmid, pLG1 (281.02 kb), in association with the vanA operon, the ermB 
gene (macrolide-lincosamide-streptogramin B resistance) and the tcrYAZB operon 
(heavy metal resistance). The hylEfm gene, an important factor involved in entero-
coccal colonization and adhesion, it has also been described as part of a genomic 
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island. The dissemination of the multi-resistant megaplasmid pLG1, carrying hylEfm 
could explain the spread of the so frequently isolated hospital-associated E. faecium 
CC17 genotype [33].
Transposable elements contribute with the genome plasticity by different 
mechanisms. They are substrates for homologous recombination within and 
between different DNA elements and rearrangements are carried out in chromo-
some and plasmid DNA [38].
In glycopeptide-resistant enterococci, vancomycin resistance is classified into 
eight acquired gene clusters: vanA, vanB, vanD, vanE, vanG, vanL, vanM and vanN. 
VanA- and VanB-type vancomycin-resistant enterococci (VRE) constitute the 
majority of VRE in clinical settings. VanA-type VRE shows high-level resistance to 
vancomycin (Minimum Inhibitory Concentration, MIC = 64–100 mg/L) and tei-
coplanin (MIC = 16–512 mg/L), while VanB-type VRE is susceptible to teicoplanin 
(MIC = 0.5–1 mg/L) and expresses different levels of resistance to vancomycin 
(MIC = 4–1000 mg/L). Also, it can be mentioned the intrinsic vanC genotype, 
found in E. gallinarum and E. casseliflavus [39, 40]. The main phenotypic and 
genotypic features of glycopeptide resistant enterococci are shown in Table 1.
The vanB gene cluster consists of a two-component regulatory system (vanRB, 
vanSB) and five resistance genes (vanYB, vanW, vanHB, vanB, vanXB). Conversely 
to the highly conserved resistance genes, the amino acid sequences of VanSB and 
VanRB show less similarity to those of VanSA and VanRA. These differences could 
be responsible for the characteristics of VanB-type resistance [41].
Furthermore, low-level vancomycin resistant E. faecium can turn into high-
level vancomycin resistant during antibiotic therapy. This variant was named 
vancomycin-variable E. faecium [20, 39, 42]. A schematic diagram of van operon is 
shown in Figure 1.
Tn1546 carries the vanA gene, and is often located on a plasmid belonging to 
the broad host range Inc18 family, involved in the vanA transfer from enterococci 
to Staphylococcus aureus. Typically, the vanA operon is associated with Tn, such as 
Tn1546, implicating two genes for the transposition of the element (orf1 and orf2), 
and one gene involved with teicoplanin resistance (vanZ). The vanA gene cluster 
includes seven open reading frames transcribed from two separate promoters. The 
regulatory apparatus is encoded by the vanR (response regulator) and vanS (sensor 
kinase) two-component system. Both are transcribed from one promoter, while 
the remaining genes are transcribed from other promoter. vanH (dehydrogenase 
that converts pyruvate to lactate) and vanA (ligase that forms D-Ala-D-Llac dipep-
tide) modify the production of peptidoglycan precursors. The production of the 
normal ending D-Ala-D-Ala of the pentapeptide does not continue. The products 
of vanX (encodes a dipeptidase that cleaves D-Ala-D-Ala) and vanY (encodes a 
D, D-carboxypeptidase) genes hydrolyze, interrupt the production of the penta-
peptides and cleave the pentapeptides that can still be produced. The variations in 
the composition of this vancomycin resistance operon is due to the insertion of IS 
elements. The vanB operon is carried by Tn1547, Tn1549 and Tn5382. Tn1549 con-
jugative Tn, is mainly located in large conjugative chromosomal elements and less 
frequently integrated in conjugative plasmids. This conjugative vanB Tn is widely 
prevalent among VanB type enterococci and other Gram-positive bacteria. The 
vanB operon has a similar genetic organization to the vanA because vanB operon 
contains two distinct promoters transcribing seven open reading frames. But vanB 
encodes a two-component signaling system (named vanRB and vanSB) that is con-
siderably different from that encoded in vanA. Furthermore, vanB encodes homo-
logs of vanH and the D-Ala-D-Ala ligase, and the peptidases (vanX and vanY). In 
addition, vanB lacks a homolog of vanZ, and instead encodes a protein vanW, with 
a role not totally explained. vanB gene (ligase) has been divided in three subtypes, 
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Phenotype VanA VanB VanD VanE VanG VanL VanM VanN VanC
Resistance Acquired Acquired Acquired Acquired Acquired Acquired Acquired Acquired Intrinsic
MICvan 16–>1000 4–>1000 16–128 8–32 16 8 >256 16 2–32
MICtei 16–512 0.25–2 2–64 0.5 0.5 0.5 96 0.5 0.12–2
Expression I I C I I I I C I, C
Mobiltiy Yes Yes No No Yes No Yes Yes No
Precursor Ala-Lac Ala-Lac Ala-Lac Ala-Ser Ala-Ser Ala-Ser Ala-Lac Ala-Ser Ala-Ser
Operon vanA vanB vanD vanE vanG vanL vanM vanN vanC
Subtypes N/A B1-B3 D1-D5 N/A G1-G2 N/A N/A N/A C1-C4
Required genes for 
expression
vanH, vanA, 
vanX
vanHB, vanB, 
vanXB
vanHD, vanD, 
vanXD
vanE, 
vanXYE, 
vanTE
vanG, 
vanXYG, 
vanTG
vanL, vanXY1, 
vanTm, vanTr1
vanHM, 
vanM, vanXM
vanN, 
vanXYN, 
vanTN
vanC, 
vanXYC, vanT
MIC, minimum inhibitory concentration (mg/L); van, vancomycin; tei, teicoplanin; I, inducible; C, constitutive; N/A, not applies. Adapted from [39, 40].
Table 1. 
Main phenotypic and genotypic features of glycopeptide-resistant enterococci.
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vanB1-3, based on nucleotidic sequence differences. vanB2 subtype is the most 
commonly spreaded in clinical enterococci. Also, is part of conjugative Tn, Tn1549/
Tn5382-like. The first description of a vanB2-Tn1549-like element in pheromone 
responsive plasmids (pCF10-like) carried by E. faecalis was reported at Japan. vanB1 
has only been described for certain isolates as part of composite Tn or an integrative 
conjugative element [21, 43–48].
It has been described that some vanA genotype isolates had a new type F Tn1546 
Tn associated with two insertion sequences: IS1216V and IS1251 [49].
The vanM cluster is similar to vanA, vanB, and vanD, while vanL and vanN are 
similar to vanC. The vanM operon has been described in VREfm isolates and showed 
a close genetic arrangement to vanD and in vitro transferable resistance by conjuga-
tion. The vanN operon is the most recently identified gene cluster described in  
E. faecium and is a similar operon to vanG, but can be transferred by MGEs only in 
this enterococcal species. The IS elements can produce structural alterations in the 
genes, and as a consequence leads to changes of resistance phenotype. The vanA gene 
cluster is prone to IS-mediated alterations, modifying sometimes the vancomycin 
resistance phenotype, as being susceptible to glycopeptides but with possibility to 
revert to a resistant phenotype. These bacteria were named vancomycin-variable 
enterococci (VVE), which could cause serious clinical issues because of their pos-
sibility to escape of detection and surveillance as well as facilitating the horizontal 
transfer of vancomycin resistance [50–52].
An additional operon (vanF) was described but only in Paenibacillus popilliae. 
This vanF cluster has a high similarity to the amino acid sequences of the vanA 
Figure 1. 
Schematic diagram of van operon. Adapted from [40].
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operon, and P. popilliae has been proposed as a possible origin for vancomycin 
resistance in enterococci [53].
3. Conclusions
The massive use of glycopeptides (vancomycin and teicoplanin) and non-
glycopeptide agents such as extended-spectrum cephalosporins in clinical settings 
have been implicated in the emergence of VREfm. Delayed effective antimicrobial 
therapy more than 48 h after the beginning of VRE bacteremia is associated with 
higher mortality rates.
The core genes bring a phylogenomic reconstruction of the E. faecium popula-
tion structure; the main contribution of accessory genes includes the adaptation of 
this species to nosocomial environments. It was observed that the plasmid com-
ponent drives host specificity, while their whole genome and chromosome share a 
common evolutionary history.
The clinical isolates´ mobilome are quite different from the other hosts. In 
VREfm the plasmid component of the pan-genome plays an important role in 
adaptation and its emergence as a nosocomial pathogen.
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